Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
137,278,139
-
Number of holders
-
169
-
Total 13F shares, excl. options
-
74,464,481
-
Shares change
-
-376,726
-
Total reported value, excl. options
-
$3,240,626,324
-
Value change
-
-$19,547,865
-
Put/Call ratio
-
59.94%
-
Number of buys
-
96
-
Number of sells
-
-69
-
Price
-
$43.52
Significant Holders of Vir Biotechnology, Inc. - Common Stock (VIR) as of Q3 2021
208 filings reported holding VIR - Vir Biotechnology, Inc. - Common Stock as of Q3 2021.
Vir Biotechnology, Inc. - Common Stock (VIR) has 169 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 74,464,481 shares
of 137,278,139 outstanding shares and own 54.24% of the company stock.
Largest 10 shareholders include SB INVESTMENT ADVISERS (UK) LTD (22,616,666 shares), Capital International Investors (8,723,656 shares), VANGUARD GROUP INC (7,220,317 shares), Temasek Holdings (Private) Ltd (5,761,045 shares), BlackRock Inc. (5,159,629 shares), BAILLIE GIFFORD & CO (3,899,692 shares), Alaska Permanent Fund Corp (3,572,438 shares), STATE STREET CORP (2,287,866 shares), ALLIANCEBERNSTEIN L.P. (2,137,492 shares), and GEODE CAPITAL MANAGEMENT, LLC (1,195,758 shares).
This table shows the top 169 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.